NCT07723287Suspended
Risk Factors for Drug-Resistant Epilepsy in Children
Risk Factors for Drug-Resistant Epilepsy in Children: A Prospective Cohort Study
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Reason given: Study hasn't stopped yet
Brief summary (registry, in English)
This prospective cohort study evaluates clinical, electroencephalographic predictors of drug-resistant epilepsy in children. Predictive statistical and machine-learning models will be developed to facilitate early identification of children at high risk for drug-resistant epilepsy.
- Status (registry)
- Suspended
- Study type
- Observational
- Enrollment
- 375 (estimated)
- First submitted
- 20 Jul 2026
- Start date
- 19 Jan 2026
- Primary completion date
- 30 Sept 2028
- Lead sponsor
- Pham Ngoc Thach University of Medicine
- Diseases
- Epilepsy
- NCT number
- NCT07723287
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Psychogenic nonepileptic seizures.
- Severe systemic illness interfering with antiseizure medication.
- Acute symptomatic seizures.
Other
- Poor treatment adherence.
- Insufficient baseline data.
- Lost to follow-up.
Who the study is looking for
- Children younger than 16 years, including neonates.
- Diagnosed with epilepsy according to International League Against Epilepsy criteria.
- Receiving treatment or follow-up at Children's Hospital 1.
- Parent or legal guardian provides informed consent.
- Expected follow-up of at least 12 months.
Age in the registry: - to 16 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital 1, Ho Chi Minh City, Vietnam | Ho Chi Minh City | Vietnam | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.